1. Home
  2. UGRO vs CURX Comparison

UGRO vs CURX Comparison

Compare UGRO & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$4.60

Market Cap

13.2M

ML Signal

HOLD

CURX

Curanex Pharmaceuticals Inc

HOLD

Current Price

$0.30

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
CURX
Founded
2014
2018
Country
United States
United States
Employees
N/A
6
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
12.4M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
UGRO
CURX
Price
$4.60
$0.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
128.8K
98.4K
Earning Date
04-15-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,399,438.00
N/A
Revenue This Year
$462.72
N/A
Revenue Next Year
$86.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.26
52 Week High
$39.68
$9.18

Technical Indicators

Market Signals
Indicator
UGRO
CURX
Relative Strength Index (RSI) 35.07 28.92
Support Level $0.28 $0.26
Resistance Level $39.68 $0.51
Average True Range (ATR) 0.81 0.02
MACD -0.10 -0.01
Stochastic Oscillator 0.00 6.41

Price Performance

Historical Comparison
UGRO
CURX

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: